From Ecstasy to MDMA: Recreational Drug Use, Symbolic Boundaries, and Drug Trends
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Misdemeanor Warrant List
SO ST. LOUIS COUNTY SHERIFF'S OFFICE Page 1 of 238 ACTIVE WARRANT LIST Misdemeanor Warrants - Current as of: 09/26/2021 9:45:03 PM Name: Abasham, Shueyb Jabal Age: 24 City: Saint Paul State: MN Issued Date Bail Amount Warrant Type Charge Offense Level 10/05/2020 415 Bench Warrant-fail to appear at a hearing TRAFFIC-9000 Misdemeanor Name: Abbett, Ashley Marie Age: 33 City: Duluth State: MN Issued Date Bail Amount Warrant Type Charge Offense Level 03/09/2020 100 Bench Warrant-fail to appear at a hearing False Pretenses/Swindle/Confidence Game Misdemeanor Name: Abbott, Alan Craig Age: 57 City: Edina State: MN Issued Date Bail Amount Warrant Type Charge Offense Level 09/16/2019 500 Bench Warrant-fail to appear at a hearing Disorderly Conduct Misdemeanor Name: Abney, Johnese Age: 65 City: Duluth State: MN Issued Date Bail Amount Warrant Type Charge Offense Level 10/18/2016 100 Bench Warrant-fail to appear at a hearing Shoplifting Misdemeanor Name: Abrahamson, Ty Joseph Age: 48 City: Duluth State: MN Issued Date Bail Amount Warrant Type Charge Offense Level 10/24/2019 100 Bench Warrant-fail to appear at a hearing Trespass of Real Property Misdemeanor Name: Aden, Ahmed Omar Age: 35 City: State: Issued Date Bail Amount Warrant Type Charge Offense Level 06/02/2016 485 Bench Warrant-fail to appear at a hearing TRAFF/ACC (EXC DUI) Misdemeanor Name: Adkins, Kyle Gabriel Age: 53 City: Duluth State: MN Issued Date Bail Amount Warrant Type Charge Offense Level 02/28/2013 100 Bench Warrant-fail to appear at a hearing False Pretenses/Swindle/Confidence Game Misdemeanor Name: Aguilar, Raul, JR Age: 32 City: Couderay State: WI Issued Date Bail Amount Warrant Type Charge Offense Level 02/17/2016 Bench Warrant-fail to appear at a hearing Driving Under the Influence Misdemeanor Name: Ainsworth, Kyle Robert Age: 27 City: Duluth State: MN Issued Date Bail Amount Warrant Type Charge Offense Level 11/22/2019 100 Bench Warrant-fail to appear at a hearing Theft Misdemeanor ST. -
City of Charleston Municipal Court
City of Charleston Municipal Court 9/24/2021 Page 1 Officer Court Events - Monday, September 27, 2021 to Friday, October 29, 2021 Excludes Motions, Deferrals, and Jury Trials Adams Christopher Tuesday, October 19, 2021 20210416019558 8:30 am Criminal Bench Trial Manucy, Majorie Disorderly Conduct Katelyn Tuesday, October 12, 2021 20210416028112 9:30 am Criminal Bench Trial Thompson, Peter Shoplifting <= $2,000 - 16 - 13-0110(A) Akins Nicholas Friday, October 1, 2021 20210415996197 8:30 am Criminal Bench Trial Rowland, Kelsi Driving Under Influence 1st Offense . No BA Thursday, October 14, 2021 20210415968789 8:30 am Traffic Bench Trial Steed, Terrell DUS, license not suspended for DUI - 1st offense (56-01-0460)(A)(1)(a) 20210416020632 8:30 am Traffic Bench Trial Hurst, Louis Driving Under Influence 1st Offense . No BA 9/24/2021 Page 2 Officer Court Events - Monday, September 27, 2021 to Friday, October 29, 2021 Excludes Motions, Deferrals, and Jury Trials Akins Nicholas Thursday, October 14, 2021 20210416023954 8:30 am Traffic Bench Trial Connolly, Colin Operating vehicle w/o reg and license due to delinquency - 56-03-0840 20210416024511 8:30 am Traffic Bench Trial Marsh, Joshua Driving Under Influence 1st Offense . No BA 8102P0769552 8:30 am Traffic Bench Trial Simmons, Jamaul DUS, license not suspended for DUI - 1st offense (56-01-0460)(A)(1)(a) Friday, October 15, 2021 20210415961061 8:30 am Criminal Bench Trial-GATEWAY INCOMPLETE Gardo, Joshua Public Drunk 20210416024512 8:30 am Criminal Bench Trial Lowe, Zackary Malicious Injury to animals, personal property, injury value $2,000 or less 20210416024513 8:30 am Criminal Bench Trial Lowe, Zackary Careless Driving Monday, October 18, 2021 20210415989747 9:00 am DUI Pre-Trial Hearing Rotibi, Katari Driving Under Influence >= .10% <.16% with BA 56-05-2930(B) 20210416013897 9:00 am DUI Pre-Trial Hearing McClelland, Bradley Driving Under Influence 1st Offense . -
MDMA and Sexual Behavior
Note: This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Substance Use & Misuse following peer review. The definitive publisher-authenticated version [McElrath K (2005) MDMA and sexual behavior: ecstasy users’ perceptions about sexuality and sexual risk, Substance Use & Misuse, 40:9, 1461-1477] is available online at http://www.informaworld.com/smpp/title~db=all~content=g714012467 MDMA and Sexual Behavior: Ecstasy Users’ Perceptions About Sexuality and Sexual Risk KAREN MCELRATH School of Sociology and Social Policy, Belfast, Ireland Published in Substance Use & Misuse,(2005) 40:9,1461—1477 This study examines the relationship between MDMA (Ecstasy), sexual behavior, and sexual risk taking. The sample consisted of 98 current and former users of MDMA. Several strategies were utilized to recruit respondents and data were collected through in-depth interviews during 1997 and 1998. The majority of respondents had used MDMA during the 6-month period prior to the interview and a large percentage had consumed the drug on 100 occasions or more. Most respondents reported feelings of emotional closeness while consuming MDMA but without the desire for penetrative sex. Others, however, reported that MDMA increased sexual arousal and some respondents (in particular gay and bisexual females) had used MDMA specifically for sexual enhancement. Sexual risk taking (e.g., having multiple partners, engaging in sex without a condom) was prevalent among respondents who did engage in sexual activity during MDMA episodes. Explanations for the findings are offered and implications for prevention/intervention are discussed. Keywords MDMA; ecstasy; sexual behavior Introduction Although a patent for 3,4-methylenedioxymethamphetamine (MDMA) was issued in 1914 (Shulgin, 1986), “recreational”a use of the drug did not surface until the 1970s and 1980s, and for the most part was restricted to selected regions in the U.S. -
DRUGGED DRIVING CONFERENCE Poly Drug
DRUGGED DRIVING CONFERENCE February 1 – 4, 2021 Phoenix, Arizona Poly Drug Use Presented by: Tom Humphrey Department of Public Safety & Dennis Milius Sergeant, Department of Public Safety Distributed by: ARIZONA PROSECUTING ATTORNEYS’ ADVISORY COUNCIL 3838 N. Central Ave, Suite 850 Phoenix, Arizona 85012 ELIZABETH BURTON ORTIZ EXECUTIVE DIRECTOR Poly Drug Use – Drug Combinations Poly Drug Use: When a person ingests drugs from two or more different drug categories. The body will exhibit a combination of effects. Poly Drug cases can be some of the more difficult cases for the DRE to evaluate. Due to the fact that the defendant has multiple drugs in his/her system, however, there may be less jury appeal for the defendant. Accordingly, they may be easier to prosecute. Note: the crime lab may only quantify some or even none of the drugs. At times the lab cannot test for all of the drugs in the system due to insufficient blood or lack of testing methods. In most cases, this should not prevent us from proceeding on the case. Alcohol is a drug. It is the most common drug used in combination with other drugs. Alcohol combined with cannabis/marijuana is currently the most common drug combination we see in Arizona. Potential Effects of Poly Drug Use Four types of combined effects can, and generally will, occur when two or more drug categories are used together: • Null Effect • Overlapping Effect • Additive Effect • Antagonistic Effect Types of Combined Effects Null Effect The simplest way to explain the null effect is using the phrase: "zero + zero = zero" Example: when a subject consumes one drug, which does not cause HGN, and they ingest another drug, which does not cause HGN, then the officer should not expect to see HGN. -
Epidemics of HIV, HCV and Syphilis Infection Among Synthetic Drugs
www.nature.com/scientificreports OPEN Epidemics of HIV, HCV and syphilis infection among synthetic drugs only users, heroin-only users and Received: 7 November 2017 Accepted: 28 March 2018 poly-drug users in Southwest China Published: xx xx xxxx Shu Su1, Limin Mao 2, Jinxian Zhao3, Liang Chen3, Jun Jing4, Feng Cheng4 & Lei Zhang 1,4,5 The number of poly-drug users who mix use heroin and synthetic drugs (SD) is increasing worldwide. The objective of this study is to measure the risk factors for being infected with hepatitis C (HCV), human immunodefciency virus (HIV) and syphilis among SD-only users, heroin-only users and poly- drug users. A cross-sectional study was conducted in 2015 from a national HIV surveillance site in Southwest China, 447 poly-drug, 526 SD-only and 318 heroin-only users were recruited. Poly-drug users have higher drug-use frequency, higher rates of drug-sharing and unsafe sexual acts than other users (p < 0.05). About a third (36.7%) of poly-drug users experienced sexual arousal due to drug efects, which is higher than the rate among other drug users. Poly-drug users had the highest prevalence of HIV (10.5%) and syphilis (3.6%), but heroin-only users had the highest prevalence of HCV (66.0%) (all p < 0.05) among three groups. Logistic regression shows among poly-drug users, having sex following drug consumption and using drugs ≥1/day were the major risk factors for both HIV (Adjusted odds ratio (AOR) = 2.4, 95% CI [1.8–3.4]; 2.3, [1.6–3.1]) and syphilis infection (AOR = 4.1, [2.1–6.9]; 3.9, [1.8–5.4]). -
MDMA ('Ecstasy'): a Review of Its Harms and Classification Under the Misuse of Drugs Act 1971
MDMA (‘ecstasy’): A REVIEW OF ITS HARMS AND CLASSIFICATION UNDER THE MISUSE OF DRUGS ACT 1971 Advisory Council on the Misuse of Drugs ACMD Advisory Council on the Misuse of Drugs 3rd Floor (SW), Seacole Building 2 Marsham Street London SW1P 4DF February 2008 Rt Hon Jacqui Smith MP Home Office 2 Marsham Street London SW1P 4DF Dear Home Secretary, The Advisory Council on the Misuse of Drugs (ACMD) recently considered that a review of MDMA (‘ecstasy’) would be timely as there is a much greater body of evidence regarding the harms and misuse of MDMA since the Council last provided its advice to Ministers in 1996. I have pleasure in enclosing the Council’s report. The use of MDMA is undoubtedly harmful. I would therefore like to emphasise that the Council continues to be concerned about the widespread use of MDMA; particularly among young people. Due to its prevalence of use, MDMA is a significant public health issue and we believe that criminal justice measures will only have limited effect. You will wish to note that the Council strongly advises the promulgation of public health messages. It is of vital importance that issues of classification do not detract from messages concerning public health. Forensic evidence shows that MDMA is by far the most commonly seized of the ‘ecstasy-like’ drugs. MDMA is presently generically classified in Class A under the Misuse of Drugs Act with other ‘ecstasy-like’ drugs. The ACMD has not extended this review to other compounds within the generic classification since their use is considerably less than that of MDMA. -
Phencyclidine: an Update
Phencyclidine: An Update U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse and Mental Health Administration Phencyclidine: An Update Editor: Doris H. Clouet, Ph.D. Division of Preclinical Research National Institute on Drug Abuse and New York State Division of Substance Abuse Services NIDA Research Monograph 64 1986 DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administratlon National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20657 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 NIDA Research Monographs are prepared by the research divisions of the National lnstitute on Drug Abuse and published by its Office of Science The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. SIDNEY COHEN, M.D. Temple University School of Medicine Los Angeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic lnstitute National Federation of Parents for Troy, New York Drug Free Youth RICHARD E. BELLEVILLE, Ph.D. Omaha, Nebraska NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTEMAN Langley Porter Neuropsychiatric lnstitute Alcohol and Drug Problems Association San Francisco, California of North America Washington, D.C. DENISE KANDEL, Ph.D GILBERT J. BOTV N, Ph.D. College of Physicians and Surgeons of Cornell University Medical College Columbia University New York, New York New York, New York JOSEPH V. -
Motor Delays in MDMA (Ecstasy) Exposed Infants Persist to 2 Years
Neurotoxicology and Teratology 54 (2016) 22–28 Contents lists available at ScienceDirect Neurotoxicology and Teratology journal homepage: www.elsevier.com/locate/neutera Motor delays in MDMA (ecstasy) exposed infants persist to 2 years Lynn T. Singer a,⁎, Derek G. Moore b,MeeyoungO.Mina, Julia Goodwin b, John J.D. Turner b, Sarah Fulton a,AndrewC.Parrottc a Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, United States b The University of East London, Docklands Campus, University Way, London E16 2RD, United Kingdom c Swansea University, Singleton Park, Swansea, Wales SA2 8PP, United Kingdom, article info abstract Article history: Background: Recreational use of 3,4 methylenedioxymethamphetamine (ecstasy, MDMA) is increasing world- Received 29 July 2015 wide. Its use by pregnant women causes concern due to potentially harmful effects on the developing fetus. Received in revised form 5 January 2016 MDMA, an indirect monoaminergic agonist and reuptake inhibitor, affects the serotonin and dopamine systems. Accepted 20 January 2016 Preclinical studies of fetal exposure demonstrate effects on learning, motor behavior, and memory. In the first Available online 21 January 2016 human studies, we found prenatal MDMA exposure related to poorer motor development in the first year of life. In the present study we assessed the effects of prenatal exposure to MDMA on the trajectory of child devel- Keywords: opment through 2 years of age. We hypothesized that exposure would be associated with poorer mental and Behavior Cocaine motor outcomes. Alcohol Materials and Methods: The DAISY (Drugs and Infancy Study, 2003–2008) employed a prospective longitudinal Teratology cohort design to assess recreational drug use during pregnancy and child outcomes in the United Kingdom. -
Recreational Drug Use: What’S the Harm?
Your Employee and Family Assistance Program is a support service that can help you take the first step toward change. Recreational drug use: what’s the harm? Recreational drug use can be defined as the use of drugs strictly for pleasure, and quite often in social situations. Recreational users are not necessarily physically or psychologically dependent on drugs, however these users do run the risk of developing a dependency. There is considerable controversy surrounding the use of drugs, and opinions vary widely from those who think all drugs should be illegal, to those who advocate for the legalization of certain drugs. Even though it is illegal to use drugs such as marijuana, cocaine, LSD, ecstasy, and amphetamines, those who choose to use these substances can find them quite readily. And many—both young and old—believe there is little or no harm to using these drugs recreationally. Why use? Recreational drug users find that using drugs, from marijuana to cocaine, can help them: improve their mood, increase excitement and enjoyment, reduce inhibitions, become more relaxed, and achieve social acceptance among their peers. These benefits are generally reported to be immediate and short-term. The negative consequences of recreational drug use, on the other hand, tend to be delayed and longer term. Escalation Any recreational drug user risks escalation of their drug use, which in turn may develop into a drug dependency. Drug use and the problems associated with it may start off as limited or small, but gradually escalate to causing bigger problems in more areas of the user's life. -
Civil Society Monitoring of Harm Reduction in Europe, 2019
Correlation Correlation European DATA REPORT Eropean Harm Reduction R C Network C Network CIVIL SOCIETY MONITORING OF HARM REDUCTION IN EUROPE, 2019 DATA REPORT 1 CIVIL SOCIETY MONITORING OF HARM REDUCTION IN EUROPE, 2019 ® Correlation – European Harm Reduction Network, 2019. This publication of Correlation – European Harm Reduction Network is protected by copyright. Reproduction is authorised provided the source is acknowledged. Recommended citation: Tammi, T., Rigoni, R., Matičič, M., Schäffer, D., van der Gouwe, D., Schiffer, K., Perez Gayo, R., Schatz, E. (2020): Civil Society Monitoring of Harm Reduction in Europe, 2019. Data Report. Correlation European Harm Reduction Network, Amsterdam. Correlation – European Harm Reduction Network c/o Foundation De REGENBOOG GROEP Droogbak 1d 1013 GE Amsterdam The Netherlands www.correlation-net.org This project has been supported by the European Commission. Correlation - European Harm Reduction Network is co-funded by the European Union 2 Correlation European DATA REPORT Harm Reduction C Network CIVIL SOCIETY MONITORING OF HARM REDUCTION IN EUROPE, 2019 DATA REPORT 3 CIVIL SOCIETY MONITORING OF HARM REDUCTION IN EUROPE, 2019 CONTRIBUTORS Editor: The data network: Graham Shaw Albania: Genci Mucollari, Aksion Plus Austria: Alexandra Karden & Barbara Siokola, Scientific expert group: Suchthilfe Wien Tuukka Tammi (THL), Dagmar Hedrich (EMCDDA), Belgium: Peter Blanckaert & Tessa Windelinckx, Sam Shirley-Beavan (HRI), Perrine Roux (INSERM). Free Clinic Bosnia and Herzegovina: Samir Ibisevic, PROI -
Recent Changes in Drug Abuse Scenario the Novel Psychoactive Substances (NPS) Phenomenon
brain sciences Recent Changes in Drug Abuse Scenario The Novel Psychoactive Substances (NPS) Phenomenon Edited by Fabrizio Schifano Printed Edition of the Special Issue Published in Brain Sciences www.mdpi.com/journal/brainsci Recent Changes in Drug Abuse Scenario Recent Changes in Drug Abuse Scenario The Novel Psychoactive Substances (NPS) Phenomenon Special Issue Editor Fabrizio Schifano MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editor Fabrizio Schifano University of Hertfordshire UK Editorial Office MDPI St. Alban-Anlage 66 4052 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Brain Sciences (ISSN 2076-3425) in 2018 (available at: https://www.mdpi.com/journal/brainsci/ special issues/drug abuse scenario) For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-507-6 (Pbk) ISBN 978-3-03897-508-3 (PDF) c 2019 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND. Contents About the Special Issue Editor ...................................... vii Fabrizio Schifano Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon Reprinted from: Brain Sci. -
Licit and Illicit Drug Use During Pregnancy: Maternal, Neonatal and Early Childhood Consequences
SUBSTANCE ABUSE IN CANADA 2013 Licit and Illicit Drug Use during Pregnancy: Maternal, Neonatal and Early Childhood Consequences By Loretta Finnegan With A Call to Action by Franco Vaccarino and Colleen Dell This document was published by the Canadian Centre on Substance Abuse (CCSA). CCSA activities and products are made possible through a financial contribution from Health Canada. The views of CCSA do not necessarily represent the views of the Government of Canada. The subjects in the photographs used throughout this publication are models who have no relation to the content. The vignettes are fictional and do not depict any actual person. Suggested citation: Finnegan, L. (2013). Substance abuse in Canada: Licit and illicit drug use during pregnancy: Maternal, neonatal and early childhood consequences. Ottawa, ON: Canadian Centre on Substance Abuse. © Canadian Centre on Substance Abuse 2013. CCSA, 75 Albert St., Suite 500 Ottawa, ON K1P 5E7 Tel.: 613-235-4048 Email: [email protected] This document can also be downloaded as a PDF at www.ccsa.ca. Ce document est également disponible en français sous le titre : Toxicomanie au Canada 2013 : Consommation de drogues licites et illicites pendant la grossesse : Répercussions sur la santé maternelle, néonatale et infantile ISBN 978-1-77178-041-4 Licit and Illicit Drug Use during Pregnancy: Maternal, Neonatal and Early Childhood Consequences Prepared for the Canadian Centre on Substance Abuse Loretta P. Finnegan, M.D., LLD, (Hon.), ScD (Hon.); President, Finnegan Consulting, LLC; Professor of Pediatrics, Psychiatry and Human Behavior, Thomas Jefferson University (Retired); Founder and Former Director of Family Center, Comprehensive Services for Pregnant Drug Dependent Women, Philadelphia, PA; Former Medical Advisor to the Director, Office of Research on Women’s Health, National Institutes of Health, U.S.